Charles Ryhee
Stock Analyst at TD Cowen
(2.44)
# 2,377
Out of 4,898 analysts
25
Total ratings
52.38%
Success rate
1%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $73 → $80 | $64.36 | +24.30% | 5 | Nov 25, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Buy | $16 → $14 | $11.51 | +21.63% | 6 | Oct 22, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $715.57 | -8.88% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $151.65 | +12.10% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $11.36 | +419.37% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $161.69 | -55.47% | 1 | Aug 16, 2022 | |
| OTRK Ontrak | Downgrades: Underperform | $3,150 → $810 | $0.49 | +166,224.44% | 2 | Aug 20, 2021 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $8.27 | +2,173.28% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $15.08 | +92.31% | 1 | Mar 29, 2021 |
CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73 → $80
Current: $64.36
Upside: +24.30%
Walgreens Boots Alliance
Oct 22, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $11.51
Upside: +21.63%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $715.57
Upside: -8.88%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $151.65
Upside: +12.10%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $11.36
Upside: +419.37%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $161.69
Upside: -55.47%
Ontrak
Aug 20, 2021
Downgrades: Underperform
Price Target: $3,150 → $810
Current: $0.49
Upside: +166,224.44%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $8.27
Upside: +2,173.28%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $15.08
Upside: +92.31%